title: Methodological issues in a study of long-term maintenance therapy with quetiapine versus haloperidol decanoate.
authors.forename: Babatunde
authors.initials: B
authors.lastname: Adetunji
authors.forename: Biju
authors.initials: B
authors.lastname: Basil
authors.forename: Maju
authors.initials: M
authors.lastname: Mathews
authors.forename: Adedapo
authors.initials: A
authors.lastname: Williams
authors.forename: Thomas
authors.initials: T
authors.lastname: Osinowo
mesh_terms: D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003987:Dibenzothiazepines / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006220:Haloperidol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007267:Injections; D011618:Psychotic Disorders / Q000188:drug therapy / Q000517:prevention & control; D000069348:Quetiapine Fumarate; D012107:Research Design / Q000592:standards; D018401:Sample Size; D012559:Schizophrenia / Q000188:drug therapy / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate; C033563:haloperidol decanoate; D006220:Haloperidol